Jill M Seargent

GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation

Jill M Seargent, Elisabeth A Yates, Jason H Gill, 2004, British journal of pharmacology.